muramylnac-ala-isogln-lys-tripeptide has been researched along with Lung Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dumont, S; Goldbach, P; Kessler, R; Poindron, P; Stamm, A | 1 |
| Benjamin, R; Bucana, CD; Fidler, IJ; Harris, MB; Jaffe, N; Kleinerman, ES; Krakoff, IH; Raymond, AK | 1 |
| Collins, M; Herberman, RB; Phillips, H; Schneider, M; Talmadge, JE; Wiltrout, RH | 1 |
1 trial(s) available for muramylnac-ala-isogln-lys-tripeptide and Lung Neoplasms
| Article | Year |
|---|---|
Unique histological changes in lung metastases of osteosarcoma patients following therapy with liposomal muramyl tripeptide (CGP 19835A lipid).
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Adolescent; Adult; Chemotherapy, Adjuvant; Female; Humans; Liposomes; Lung Neoplasms; Male; Osteosarcoma; Phosphatidylethanolamines | 1992 |
3 other study(ies) available for muramylnac-ala-isogln-lys-tripeptide and Lung Neoplasms
| Article | Year |
|---|---|
In situ activation of mouse alveolar macrophages by aerosolized liposomal IFN-gamma and muramyl tripeptide.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Aerosols; Animals; Antineoplastic Agents; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Carriers; Interferon-gamma; Kinetics; Liposomes; Lung Neoplasms; Macrophage Activation; Macrophages, Alveolar; Male; Mice; Mice, Inbred C57BL; Phosphatidylethanolamines; Recombinant Proteins; Tumor Cells, Cultured | 1996 |
A special grant for special patients from the American Cancer Society.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Bone Neoplasms; Financial Management; Financing, Personal; Fund Raising; Humans; Lung Neoplasms; Osteosarcoma | 1990 |
Augmentation of NK cell activity in tissue specific sites by liposomes incorporating MTP-PE.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Cytotoxicity, Immunologic; Fibrosarcoma; Killer Cells, Natural; Liposomes; Liver; Lung; Lung Neoplasms; Lymphoma; Male; Mice; Mice, Inbred C3H; Phosphatidylethanolamines; Spleen | 1985 |